April 27, 2020 Rentschler Biopharma’s COVID-19 Response
In these unprecedented times, we at Rentschler Biopharma, are deeply committed to safeguarding the reliable delivery of essential, sometimes lifesaving, therapeutics for our clients and their patients. At the same time, we are strongly dedicated to ensuring the safety of our employees and our partners.
Having been classified as a "systemically important" company in Germany, we recognize our responsibility in coping with the current crisis. We have reacted swiftly to the evolving challenge of the COVID-19 outbreak. Our task force, especially activated for infection prevention, has been assessing the situation in real-time. In alignment with local health authorities and the help of our business continuity plan, it is consistently driving comprehensive company-wide measures to adapt to the changing situation.
With these measures in place, we have successfully secured ongoing operations and supply continuity to best support our clients in these challenging times. For additional information, please do not hesitate to reach out to firstname.lastname@example.org.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication